Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Cash flows from operating activities:
Net income (loss)	$ 798,236	$ (479,338)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
Depreciation and amortization	2,655,418	2,797,143
Stock compensation	568,701	582,199
Bad debt expense	13,416	0
Gain on sale of real estate assets, net	(2,750,269)	(1,433,014)
Gain on extinguishment of government debt	0	(10,000)
Net change in fair value marketable securities	156,891	19,785
Impairment of real estate assets	0	300,000
Amortization of financing costs	125,850	371,201
Amortization of above-market leases	0	36,055
Amortization of below-market leases	(27,445)	(34,450)
Straight-line rent adjustment	(46,305)	(170,554)
Changes in operating assets and liabilities:
Other assets	317,942	246,728
Accounts payable and accrued liabilities	(1,284,696)	(938,461)
Accrued real estate taxes	(987,636)	(1,607,985)
Net cash used in operating activities	(459,897)	(320,691)
Cash flows from investing activities:
Real estate acquisitions	(4,646,330)	(2,851,800)
Additions to buildings and tenant improvements	(832,990)	(332,508)
Investment in marketable securities	(661,247)	(756,178)
Proceeds from sale of marketable securities	1,111,608	63,456
Investment of SPAC IPO proceeds into Trust Account	(134,895,000)	0
Additions to deferred leasing costs	(35,864)	(73,491)
Proceeds from sales of real estate, net	18,839,913	44,335,436
Net cash provided by (used in) investing activities	(121,119,910)	40,384,915
Cash flows from financing activities:
Proceeds from mortgage notes payable, net of issuance costs	12,590,235	8,003,807
Repayment of mortgage notes payable	(7,361,659)	(38,077,499)
Repayment of note payable	0	(7,675,598)
Payment of deferred offering costs	(3,201,266)	(214,982)
Distributions to noncontrolling interests, net	(2,614,352)	(2,779,096)
Proceeds from initial public offering of SPAC	132,250,000	0
Issuance of Preferred Stock Series D, net of offering costs	0	20,489,803
Repurchase of common stock, at cost	(30,729)	0
Dividends paid to preferred stockholders	(1,078,112)	0
Dividends paid to common stockholders	(2,609,454)	(2,008,184)
Net cash provided by (used in) financing activities	127,944,663	(22,261,749)
Net increase (decrease) in cash equivalents and restricted cash	6,364,856	17,802,475
Cash, cash equivalents and restricted cash - beginning of period	14,702,089	11,540,917
Cash, cash equivalents and restricted cash - end of period	21,066,945	29,343,392
Non-cash financing activities:
Unpaid deferred financing costs	0	35,000
Deferred offering cost SPAC, underwriting commission payable	4,628,750	0
Dividends payable - Preferred Stock Series D	179,685	95,836
Mortgage Notes [Member]
Supplemental disclosure of cash flow information:
Interest paid	1,971,942	2,400,367
Notes Payable [Member]
Supplemental disclosure of cash flow information:
Interest paid	$ 0	$ 103,861